- Home
- PRZO vs OSRH Comparison
PRZO vs OSRH Comparison
Compare PRZO & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | PRZO | OSRH |
|---|---|---|
| Founded | 2014 | N/A |
| Country | Israel | United States |
| Employees | N/A | 22 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6M | 17.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRZO | OSRH |
|---|---|---|
| Price | $0.51 | $0.42 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 430.7K | ★ 538.4K |
| Earning Date | 03-26-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $0.30 |
| 52 Week High | $2.15 | $1.24 |
Technical Indicators
Market Signals| Indicator | PRZO | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 60.62 |
| Support Level | $0.45 | $0.39 |
| Resistance Level | $0.57 | $0.45 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 50.08 | 93.17 |
Price Performance
Historical ComparisonAbout PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.